Pressure BioSciences, Inc. reported significant financial developments in its 10-Q filing for the quarter ending March 31, 2024. The company’s total assets surged to $6,991,529, a notable increase from $1,049,676 as of December 31, 2023. Current assets also rose to $957,257, up from $760,055 at the end of the previous year. However, current liabilities experienced a substantial increase, climbing to $45,118,325 from $33,803,505, indicating a rise in financial obligations. This resulted in a total stockholders' deficit of $(38,126,796) as of March 31, 2024, compared to $(32,753,829) at the end of 2023.
In terms of revenue, Pressure BioSciences reported total revenue of $349,257 for the three months ended March 31, 2024, reflecting a 53% decline from $740,600 in the same period of 2023. Despite the drop in revenue, total operating costs decreased significantly to $1,833,815 from $4,378,345 in Q1 2023. This led to an operating loss of $(1,484,558) for Q1 2024, which represents a 59% improvement compared to the $(3,637,745) loss reported in Q1 2023.
The net loss attributable to common shareholders for Q1 2024 was $(8,706,476), or $(0.22) per share, compared to $(7,289,641), or $(0.46) per share, in Q1 2023. Additionally, net cash used in operating activities increased significantly to $(1,859,560) from $(422,211) in the prior year. Conversely, net cash provided by financing activities rose to $1,781,501 in Q1 2024, compared to $660,369 in Q1 2023.
A strategic development during this period includes the completion of the acquisition of Uncle Bud’s Health & Wellness in January 2024, which is anticipated to enhance the company’s product offerings and market reach.
About PRESSURE BIOSCIENCES INC
About 10-Q Filings
A 10-Q form is an important financial report that public companies in the United States must submit every three months. It gives a clear picture of a company's financial health and recent performance.
Key points about the 10-Q:
- Frequency: Companies file it three times a year, covering the first three quarters. The fourth quarter is covered in a more comprehensive annual report.
-
Content: It includes:
- Financial statements showing the company's current financial position
- Updates from management on the performance and projections of the business
- Information about potential risks the company faces
- Details on how the company is run internally
- Deadline: Must be filed within 40 or 45 days after the quarter ends, depending on the size of the company.
Our Methodology
AssetRoom is committed to providing timely summaries of news from public companies. We use AI to generate these summaries quickly, but they are not reviewed by human experts.
Our method:
- Data Collection: We continuously monitor for new filings (currently limited to US-listed stocks).
- AI-Powered Analysis: Our advanced AI system processes each filing, identifying key information and extracting relevant data.
- Summary Generation: The AI creates a concise, easy-to-understand summary of the filing, highlighting the most important points.
- Publication: The summary is immediately published on our platform, allowing users instant access to the latest information.
- Email users: We distribute round-up emails according to our users preferences, keeping them in the loop with the companies they follow.
Feedback & Corrections
Spot an error or have a suggestion? Contact us.